Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

PFE holding history

Pfizer Inc in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

PFE overviewAll 13F holders of PFEFull Q2 2026 holdings

Shares (Q2 2026)
18,148,158
Value
$437.0M
% of portfolio
0.1%
Quarters held
22
Since Q1 2021
Holdings of PFE by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202618,148,158$437.0M0.1%+539,008+3.1%AddedHolders
Q1 202617,609,150$494.5M0.1%+811,135+4.8%AddedHolders
Q4 202516,798,015$418.3M0.1%−4,998,601−22.9%ReducedHolders
Q3 202521,796,616$555.4M0.1%−2,021,043−8.5%ReducedHolders
Q2 202523,817,659$577.3M0.1%−1,2320.0%ReducedHolders
Q1 202523,818,891$603.6M0.1%−3,220,014−11.9%ReducedHolders
Q4 202427,038,905$717.3M0.2%+3,795,376+16.3%AddedHolders
Q3 202423,243,529$672.7M0.2%+3,292,353+16.5%AddedHolders
Q2 202419,951,176$558.2M0.2%+3,334,517+20.1%AddedHolders
Q1 202416,616,659$461.1M0.2%+1,560,892+10.4%AddedHolders
Q4 202315,055,767$433.5M0.2%+338,325+2.3%AddedHolders
Q3 202314,717,442$488.2M0.2%−1,749,197−10.6%ReducedHolders
Q2 202316,466,639$604.0M0.3%−2,153,286−11.6%ReducedHolders
Q1 202318,619,925$759.7M0.4%+726,356+4.1%AddedHolders
Q4 202217,893,569$916.9M0.4%+2,991,764+20.1%AddedHolders
Q3 202214,901,805$652.1M0.4%−2,177,923−12.8%ReducedHolders
Q2 202217,079,728$895.5M0.5%+294,801+1.8%AddedHolders
Q1 202216,784,927$869.0M0.4%−708,211−4.0%ReducedHolders
Q4 202117,493,138$1.03B0.4%+200,653+1.2%AddedHolders
Q3 202117,292,485$743.7M0.3%+251,439+1.5%AddedHolders
Q2 202117,041,046$667.3M0.3%−1,742,222−9.3%ReducedHolders
Q1 202118,783,268$680.5M0.3%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.